Evidence map›Paper›PMID 35014690›Full record

ArticleMolecular medicine reports2022

Activation of neurotrophin signalling with light‑inducible receptor tyrosine kinases.

Wei Zhang, Shu Zhao, Linjie Lu, Zhimin Fan, Shixin Ye

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Receptor Tyrosine Kinase Signaling InvolvesTropical medicine and infectious disease · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Wei Zhang *Anesthesiology Department, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210000, P.R. China.
Shu Zhao *School of Life Science, Nantong University, Nantong, Jiangsu 226019, P.R. China.
Linjie LuInstitute of Genetics, Molecular and Cellular Biology, University of Strasbourg, Illkirch 67400, France.
Zhimin FanAnesthesiology Department, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210000, P.R. China.
Shixin YeInstitut National de la Sante et de la Recherche Medicale (INSERM) U1195, Bicetre Hospital, Paris‑Saclay University, Le Kremlin-Bicêtre 94276, France.
Nanjing University of Chinese Medicine · CNBicêtre Hospital · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optogenetics combined with protein engineering based on natural light‑sensitive dimerizing proteins has evolved as a powerful strategy to study cellular functions. The present study focused on tropomyosin kinase receptors (Trks) that have been engineered to be light‑sensitive. Trk belongs to the superfamily of receptor tyrosine kinases (RTKs), which are single‑pass transmembrane receptors that are activated by natural ligands and serve crucial roles in cellular growth, differentiation, metabolism and motility. However, functional variations exist among receptors fused with light‑sensitive proteins. The present study proposed a signal transduction model for light‑induced receptor activation. This model is based on analysis of previous light‑induced Trk receptors reported to date and comparisons to the activation mechanism of natural receptors. In this model, quantitative differences on the dimerization induced from either top‑to‑bottom or bottom‑to‑up may lead to the varying amplitude of intracellular signals. We hypothesize that the top‑to‑bottom propagation is more favourable for activation and yields better results compared with the bottom‑to‑top direction. The careful delineation of the dimerization mechanisms fine‑tuning activation will guide future design for an optimum cellular output with the precision of light.

Indexed as

DimerizationHumansLightLight Signal TransductionModels, BiologicalNerve Growth FactorsReceptor, InsulinReceptor Protein-Tyrosine KinasesReceptor, trkANerve Growth FactorsNTRK1 protein, humanReceptor, InsulinReceptor Protein-Tyrosine KinasesReceptor, trkAneurotrophin signallingoptogeneticsreceptor tyrosine kinases neuronal growth factorstropomyosin kinase receptors

Identifiers

PMID35014690
PMCPMC8767455
OpenAlexW4206691254

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.